Home
About
Publications Trends
Recent Publications
Expert Search
Archive
neuromuscular complications
What are Paraneoplastic Neurological Syndromes?
Paraneoplastic Neurological Syndromes (PNS) occur when cancer triggers an immune response that attacks the nervous system. Examples include:
-
Lambert-Eaton Myasthenic Syndrome
: Characterized by muscle weakness.
-
Paraneoplastic Cerebellar Degeneration
: Affects coordination and balance.
-
Opsoclonus-Myoclonus Syndrome
: Involves rapid eye movements and muscle jerks.
Frequently asked queries:
What are Neuromuscular Complications in Cancer?
How does Cancer Lead to Neuromuscular Complications?
Which Cancers are Most Often Associated with Neuromuscular Complications?
What are Paraneoplastic Neurological Syndromes?
How is Diagnosis Made?
Can Neuromuscular Complications be Prevented?
Who is a Candidate for VATS?
What is the Role of Regression Analysis?
What is Acute Renal Failure?
What genes are regulated by HIF-1α?
What is the Importance of Molecular Pathology in Cancer?
How Often Should High-Risk Individuals Get Chest X-Rays?
Can the Microbiome Affect Cancer Treatment?
What Is the Prognosis for Cognitive Recovery?
Why is the Turnbull Estimator Important in Cancer Research?
How to Access a Comprehensive Cancer Center?
How is ICG Administered?
What Role Does Nutrition Play in QoL for Cancer Patients?
How does quitting smoking affect cancer screening and detection?
What are the Implications of Low Hematocrit in Cancer Patients?
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Lung Cancer
Nanotechnology
Non-Hodgkin’s Lymphoma
Radiation-Induced Malignancies
Follow Us
Facebook
Linkedin
Youtube
Instagram
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
Carcinogenesis
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
Chronic inflammation
CIAbimatoprost
Co-morbidity
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
Diagnosis challenges
diffuse large B-cell lymphoma
DNA damage
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Fibrosis
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunosuppression
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
intensity-modulated radiation therapy
Keratinocyte
Lipid-based nanoparticles
liver cancer
long-term cancer risks
Lung cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Multidisciplinary care
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
proton therapy
Radiation-induced malignancies
radiotherapy
refractory lymphoma
relapsed lymphoma
Risk factors
secondary cancer prevention
secondary cancers
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
Tuberculosis
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe